Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise? - Wikidata - wikimedia - TriplyDB

Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?

Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?

http://www.wikidata.org/entity/Q42684464

about

Trial watch: Immune checkpoint blockers for cancer therapy.

P2860

Q47393365-2E035008-8ED1-4F9C-BD9B-804A9D7AA7D5

P2860

Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?

http://www.wikidata.org/entity/Q42684464

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?

@en

Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?

@nl

type

label

Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?

@en

Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?

@nl

prefLabel

Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?

@en

Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?

@nl

P1433

Q42684464-39C1A9E9-51FC-4152-AE95-A7A190F85F13

P1476

Q42684464-BC535EB0-3592-4A4E-9D93-0867C56651DF

P2093

Q42684464-004388BA-6C87-4CAC-960A-7621D5F9269E

Q42684464-12741160-11B2-466E-8721-338B6C170847

P2860

Q42684464-3FF53A74-9E30-4AB5-BF4F-9C729D7B3F13

Q42684464-4983CBF4-F6DA-4957-9343-CE21A9B9AFBB

Q42684464-6C00838F-0634-427C-918E-291436ABA9DA

Q42684464-8BF4EA43-56E2-4375-AB7C-C0C06EC68412

Q42684464-9A1D3485-2621-40D7-A75C-CAE9060F3D56

Q42684464-B4B213AD-4094-4F1F-BE7A-283AD488E446

Q42684464-C259CB23-309E-44EC-9468-8ABF4527F177

Q42684464-C75F0F8E-640B-45C9-8D02-9DF2ECD9341A

Q42684464-C7F0CAC9-58DB-4F6C-BA9C-6D3A89D949DF

Q42684464-E1236F9A-0442-4CE1-A502-E9B558CFD56B

P304

Q42684464-E5954638-3E27-4424-BF90-8D73192929B5

P31

Q42684464-1A68E9A3-487F-4C5F-A392-B01AE68A67A5

P356

Q42684464-A3ACF17C-20D3-4157-87D9-EFBB04C73153

P407

Q42684464-2793B2EC-5160-4386-80EB-623E231EDBAD

P433

Q42684464-1FD2E066-EF6D-4D5D-8F84-BA8530048492

P478

Q42684464-60F37730-39EE-4F83-9C4E-130995C00CE3

P577

Q42684464-9DE3DE20-47BC-4CE6-8C6A-033AE098BD2A

P698

Q42684464-67FBC815-F3BC-4AE7-83D6-0FBA5DD51038

P932

Q42684464-ED451E66-4883-4603-9894-465257974C7F

P356

1078-0432.CCR-16-1582

P1433

Clinical Cancer Research

P1476

Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?

@en

P2093

Jeffrey S Miller

http://www.w3.org/2001/XMLSchema#string

Martin Felices

http://www.w3.org/2001/XMLSchema#string

P2860

A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma.

Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma

Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma.

Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.

Unifying concepts of MHC-dependent natural killer cell education.

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect.

Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma.

In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: maintained tolerance to normal cells even in the presence of IL-2.

A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma.

P304

5161-5163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-16-1582

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27430580

http://www.w3.org/2001/XMLSchema#string

P932

5093060

http://www.w3.org/2001/XMLSchema#string